Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001104659-25-095177
Filing Date
2025-09-30
Accepted
2025-09-30 18:12:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2878
  Complete submission text file 0001104659-25-095177.txt   4553
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Subject) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36296 | Film No.: 251361861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CARISMA THERAPEUTICS INC. 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA 19104
Business Address
Klichinsky Michael (Reporting) CIK: 0001967221 (see all company filings)

Type: 144